TD Cowen highlights this stock as a best SMID-cap idea with multiple 2026 catalysts

July 2, 2026 12:00 AM

Investing.com-- TD Cowen named a gene therapy company one of its best small- and mid-cap ideas for 2026, reiterating its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found